C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2002
11/26/2002	US6485937 System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae
11/26/2002	US6485902 Use of bacteriophages for control of escherichia coli O157
11/26/2002	US6485728 Mimicing the conformational neutralizing epitopes on papilloma virions
11/26/2002	CA2186034C Highly efficient production and isolation of viral particles
11/26/2002	CA2051289C Viral mediated destruction of neoplastic cells
11/26/2002	CA1341403C Recombinant a vipox virus
11/21/2002	WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002	WO2002092826A2 Composition and method for treating cancer using herpes virus
11/21/2002	WO2002092825A2 Retroviral vectors for gene therapy
11/21/2002	WO2002092796A1 Papilloma pseud-virus and it's preparation
11/21/2002	WO2002092786A2 A helper dependent adenoviral vector system and methods for using the same
11/21/2002	WO2002091997A2 Oncolytic virus therapy
11/21/2002	WO2002091994A2 Composition and method for increasing cell density in cell cultures infected with lentivirus
11/21/2002	WO2002077211A8 A virus (cryptovirus) within the rubulavirus genus and uses therefor
11/21/2002	WO2001025465A9 Adeno-associated viruses and uses thereof
11/21/2002	WO2001025462A9 Production of recombinant aav using adenovirus comprising aav rep/cap genes
11/21/2002	US20020173038 Retroviral packaging cassettes amplified in the cytoplasm by autocatalytic togavirus vectors
11/21/2002	US20020173030 Lenitiviral packaging system for use as tool in genetic engineering
11/21/2002	US20020172941 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
11/21/2002	US20020172940 Methods and reagents for isolating biologically active peptides
11/21/2002	US20020172939 DNA, RNA, amino acid sequences for detecting antibodies against retroviruses which are associated with immunodeficiency diseases; diagnosis
11/21/2002	US20020172690 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/21/2002	US20020172688 HLA-restricted cytotoxic T-Lymphocytevaccine for prevention of HIV infection
11/21/2002	US20020172683 Used for therapy of viral pathologies, such as those due to HIV-1 or HIV-2 infections, for screening compounds
11/21/2002	US20020170859 Purification of biological substances
11/21/2002	CA2446131A1 Composition and method for increasing cell density in cell cultures infected with lentivirus
11/21/2002	CA2442144A1 A helper dependent adenoviral vector system and methods for using the same
11/20/2002	EP1257671A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof
11/20/2002	EP1257661A1 AN ASSAY FOR DETECTING VARIANT HAPATITIS B VIRUSES (HBVs) WHICH EXHIBIT ALTERED SENSITIVITY TO AGENTS
11/20/2002	EP1257656A2 Recombinant aav packaging systems
11/20/2002	EP1257642A1 Partners of ptb1 domain of fe65, preparation and uses
11/20/2002	EP1257569A2 Cold-adapted equine influenza viruses
11/20/2002	CN1380420A New-type adenovirus with tumor cell specific infection and transgenic expression capability
11/20/2002	CN1380392A Recombinant adenovirus of coexpression human P53 gene and human cytokine gene and its preparation method and application
11/19/2002	US6482634 Methods and vector constructs useful for production of recombinant AAV
11/19/2002	US6482633 Accessory functions for use in recombinant AAV virion production
11/19/2002	US6482632 Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof
11/19/2002	US6482617 Viable contaminant particle free adenoviruses, their preparation and use
11/19/2002	US6482587 Methods to inhibit or enhance the binding of viral DNA to genomic host DNA
11/19/2002	US6482585 Storage and maintenance of blood products including red blood cells and platelets
11/19/2002	US6482414 Cold-adapted equine influenza viruses
11/14/2002	WO2002090550A2 Method for preparing recombinant poxvirus
11/14/2002	WO2002089840A1 Recombinant bicistronic flaviviruses and methods of use thereof
11/14/2002	WO2002089728A2 Recombinant rhabdoviruses as live-viral vaccines
11/14/2002	WO2002089586A1 Lung epithelial cell line for propagating viruses
11/14/2002	US20020169306 Paramyxoviral vectro for use as diagnostic tools in genetic engineering
11/14/2002	US20020168764 Generation and recovering of preferential viral particles; obtain cells, infect with virus, extract virus from cells using detergent, recover virus
11/14/2002	US20020168628 Variant of LAV viruses
11/14/2002	US20020168385 Adeno-associated virus vector for boosting immunogenicity of cells
11/14/2002	US20020168384 Vaccine for poultry respiratory disorders
11/14/2002	US20020168379 Veterinary medicine; swine respiratory system disorders
11/14/2002	US20020168349 A viral DNA construct encoding for a virus capable of replication in a human or animal tumor cell and causing death of such tumor cells
11/14/2002	DE10120265A1 AAV-Helferplasmide zur Helfervirus-freien Verpackung und Pseudotypisierung von AAV-Vektoren AAV helper plasmids for helper virus-free packaging and Pseudotyping AAV vectors
11/13/2002	EP1255849A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255815A1 Porcine reproductive and respiratory syndrome virus and methods of use
11/13/2002	EP0671926B1 Immunomodulatory peptides
11/13/2002	EP0606452B1 Vector vaccines of recombinant feline herpesvirus
11/13/2002	CN1379820A Lentiviral vectors for preparation of immunotherapeutical compositions
11/13/2002	CN1379683A 疫苗 Vaccine
11/12/2002	US6479290 Chimeric adenoviral vectors
11/12/2002	US6479273 Filtration method for separating viruses
11/12/2002	CA2065245C Recombinant negative strand rna virus expression systems and vaccines
11/12/2002	CA2055963C Chimeric fibroblast growth factor
11/07/2002	WO2002088369A1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
11/07/2002	WO2002088347A2 Aav helper plasmids for helper virus-free packaging and pseudo typification of aav vectors
11/07/2002	WO2002088339A2 Bursal disease virus-like particles
11/07/2002	WO2002088338A2 Method for replicating the hepatitis c virus
11/07/2002	WO2002088327A1 Methods for viral oncoapoptosis in cancer therapy
11/07/2002	WO2002044348A3 Method for purifying adenoviruses
11/07/2002	WO2001046408A9 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
11/07/2002	US20020165347 Polypeptide for use in the diagnosis, prevention and treatment of arteriosclerosis and vascular restenosis
11/07/2002	US20020165190 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same
11/07/2002	US20020165128 Compositions and methods for proteolytically inactivating infectious agents using lactoferrin and related molecules
11/07/2002	US20020164802 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
11/07/2002	US20020164799 Expression vector coding proteins for use in the treatment of cancer
11/07/2002	US20020164789 Suppressing glial cell activation in central nervous system; obtain mammal with brain disorder, administer modulator of nervous system activity, evaluate for adjusstment in brain disorder
11/07/2002	US20020164787 Immortal cell line derived from grouper Epinephelus coioides and its applications therein
11/07/2002	US20020164783 Nucleotide sequences coding polypeptide for use in the treatment of hereditary respiratory system disorders
11/07/2002	US20020164782 Adenovirus vectors for gene therapy
11/07/2002	US20020164770 DNA transfection system for the generation of infectious influenza virus
11/07/2002	US20020164583 Targeting viral vectors to specific cells
11/07/2002	US20020164582 Nucleotide sequences coding protein for use in the treatment of viral diseases
11/07/2002	US20020164356 Attenuated recombinant rabies virus mutants and live vaccines thereof
11/07/2002	US20020164355 Test to detect antibodies; calibration
11/07/2002	US20020164353 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier
11/07/2002	US20020164350 Chimeric papillomavirus-like particles
11/07/2002	US20020164321 Compositions and methods for treating retroviral infections
11/07/2002	US20020164305 Integrin fusion protein; binding to antibodies
11/07/2002	CA2445596A1 Method for replicating the hepatitis c virus
11/07/2002	CA2439199A1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
11/06/2002	EP1254229A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
11/06/2002	EP1254213A2 Recombinant attenuation of prrsv
11/06/2002	CN1377959A Process for high efficiently multiplying hepatitis C virion and its component
11/06/2002	CN1093881C Process for preparation of immunogens or diagnostic reagents, and method for obtaining immunogens or diagnostic reagents
11/05/2002	US6475786 Amphotropic retrovirus packaging cell line, process for its production and use thereof
11/05/2002	US6475770 Processes for preparation of Marek's Disease using continuous mammalian cell lines
11/05/2002	US6475769 Methods and cell line useful for production of recombinant adeno-associated viruses
11/05/2002	US6475757 Expression vector; for use as tools in genetic engineering
11/05/2002	US6475756 Development of viruses resistant to inactivation by the human complement system

1 ... 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 ... 267